ADVFN US – Market Content Editor
-

LuxExperience shares slide 7% as Mytheresa’s strength fails to counter broader group weakness
LuxExperience B.V. (NYSE:LUXE) reported disappointing fiscal first-quarter 2026 results on Wednesday, as strong momentum at Mytheresa was unable to offset deeper losses in the company’s other divisions. Shares fell 7.65% in pre-market trading after the release. The group posted a loss of €0.61 per share, far wider than analyst expectations of a €0.25 loss, while…
-

TJX shares climb after retailer tops Q3 earnings and revenue forecasts
Shares of The TJX Companies, Inc. (NYSE:TJX) moved 2.8% higher on Wednesday after the off-price retail giant delivered third-quarter results that beat Wall Street expectations on both the top and bottom lines. TJX reported adjusted earnings per share of $1.28, surpassing analyst estimates of $1.23. Quarterly revenue came in at $15.1 billion, ahead of the…
-

Griffon tops Q4 expectations as HBP division continues to outperform
Griffon Corporation (NYSE:GFF) delivered stronger-than-expected fourth-quarter results on Wednesday, with adjusted earnings of $1.54 per share, edging past analyst forecasts of $1.51, and revenue of $662.2 million, beating consensus estimates of $631.41 million. Quarterly sales ticked up from $659.7 million a year earlier, supported primarily by continued strength in the Home and Building Products (HBP)…
-

Nayax stock drops nearly 7% after Q3 earnings fall short and 2025 outlook is cut
Nayax Ltd. (NASDAQ:NYAX) shares slid 6.95% in premarket trading Wednesday after the global payments and commerce platform posted third-quarter results that came in below Wall Street expectations and trimmed its full-year revenue targets, citing delays in merger and acquisition activity. For the quarter, Nayax reported net income of $3.5 million, translating to earnings of $0.09…
-

BingEx posts stronger Q3 profitability despite 13% drop in annual revenue
BingEx Limited (NASDAQ:FLX), one of China’s major providers of on-demand dedicated courier services, released its third-quarter 2025 results on Wednesday, showing that profits improved even as revenue continued to soften. The company reported adjusted earnings per share of $0.03, while revenue totaled $141.2 million, marking a 13% decline from the prior year. Revenue slipped from…
-

SEMrush shares skyrocket after report says Adobe is close to striking $1.9 billion takeover
SEMrush Holdings (NYSE:SEMR) surged 67% on Wednesday after The Wall Street Journal reported that Adobe (NASDAQ:ADBE) is on the verge of acquiring the SEO analytics company in a deal valued at roughly $1.9 billion. Citing people familiar with the negotiations, the report said Adobe is prepared to pay $12 per share, a hefty premium compared…
-

Valvoline shares climb 2% as upbeat 2026 outlook outweighs slight Q4 earnings miss
Valvoline Inc. (NYSE:VVV) reported fourth-quarter results on Wednesday that fell a bit short of Wall Street expectations, but the company’s stronger-than-anticipated revenue forecast for fiscal 2026 helped lift the stock 2.01% in pre-market trading. For the quarter, Valvoline posted adjusted EPS of $0.45, narrowly missing the consensus estimate of $0.47. Quarterly revenue totaled $454 million,…
-

Dycom lifts revenue guidance and unveils $1.95B Power Solutions acquisition; shares surge
Dycom (NYSE:DY) saw its stock jump roughly 9% on Wednesday after the company posted strong quarterly results, raised the midpoint of its full-year revenue forecast, and revealed a major deal to acquire Power Solutions for $1.95 billion. The acquisition, which will expand Dycom’s presence in data center electrical infrastructure, is slated to close before the…
-

Bullish shares climb as record adjusted revenue fuels strong Q3 performance
Bullish (NYSE:BLSH), the institutional digital asset exchange, delivered its strongest quarter yet on Wednesday, reporting record adjusted revenue and EBITDA for the third quarter of 2025. Adjusted revenue surged to $76.5 million, up sharply from $44.6 million a year earlier and ahead of Wall Street forecasts. Shares of the company rose 3.20% in premarket trading…
-

Agios Pharmaceuticals plunges as Phase 3 sickle cell results deliver a mixed picture
Agios Pharmaceuticals (NASDAQ:AGIO) saw its shares drop 12% after releasing Phase 3 RISE UP trial data for mitapivat in sickle cell disease, revealing a combination of encouraging and disappointing outcomes. The study succeeded on its primary goal: 40.6% of patients treated with mitapivat achieved a hemoglobin increase of at least 1.0 g/dL, compared with just…